Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jazz Pharmaceuticals PLC

102.05
-8.0700-7.33%
Post-market: 101.28-0.7700-0.75%18:17 EDT
Volume:2.41M
Turnover:243.66M
Market Cap:6.20B
PE:11.80
High:108.08
Open:108.04
Low:96.28
Close:110.12
Loading ...

Jazz Pharmaceuticals Raised to Buy From Neutral by UBS

Dow Jones
·
07 Mar

Positive Outlook for Jazz Pharmaceuticals: Buy Rating Backed by Strong Growth Prospects and Strategic Focus

TIPRANKS
·
07 Mar

Jazz Pharmaceuticals upgraded to Buy from Neutral at UBS

TIPRANKS
·
07 Mar

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals

Zacks
·
07 Mar

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More

Zacks
·
07 Mar

Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW251

Benzinga
·
07 Mar

Update: Truist Raises PT on Jazz Pharmaceuticals to $230 From $220 on Heels of Announced Purchase of Chimerix, Keeps Buy Rating

MT Newswires Live
·
07 Mar

AXSM Settles Sunosi Patent Litigation With Hikma Pharmaceuticals

Zacks
·
06 Mar

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

Zacks
·
06 Mar

Jazz Pharmaceuticals price target raised to $230 from $220 at Truist

TIPRANKS
·
06 Mar

Beat Market Volatility With 4 Low-Beta Stocks: PGR, PSO, TXO & JAZZ

Zacks
·
06 Mar

Truist Raises Price Target on Jazz Pharmaceuticals to $230 From $220, Keeps Buy Rating

MT Newswires Live
·
06 Mar

3 Highly Ranked Medical Stocks to Buy Amid Recent Market Volatility: JAZZ, OPCH, PCRX,

Zacks
·
06 Mar

Executive VP & Chief Legal Officer Neena Patil Sold A Bunch Of Shares In Jazz Pharmaceuticals

Simply Wall St.
·
06 Mar

Jazz Pharma Seen Poised to Do More Deals -- Market Talk

Dow Jones
·
06 Mar

Stifel Nicolaus Keeps Their Buy Rating on Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
06 Mar

Chimerix deal represents ‘clear strategic fit’ for Jazz, says Stifel

TIPRANKS
·
06 Mar

Jazz Pharmaceuticals Price Target Maintained With a $210.00/Share by Needham

Dow Jones
·
06 Mar

Chimerix a Prime Acquisition Candidate for Jazz Pharmaceuticals Due to Dordaviprone, Wedbush Says

MT Newswires Live
·
05 Mar

Chimerix Shares Take Flight on Takeover by Jazz Pharmaceuticals

Dow Jones
·
05 Mar